ETHZilla’s NASDAQ Relaunch Showcases $419M Ethereum Treasury
The recently rebranded company now holds 94,675 ETH, demonstrating a strong commitment to the long-term value of Ethereum, backed by Polychain, Founders Fund, and prominent DeFi founders.
Summary
- ETHZilla makes its entry on NASDAQ with a $419 million treasury of Ethereum, moving from its previous life as biotech company 180 Life Sciences.
- With the support of Polychain, Founders Fund, and DeFi leaders, ETHZilla aims to establish itself as a major corporate holder of ETH.
In a press release dated August 18, ETHZilla Corporation announced its transition from biotech firm 180 Life Sciences to a dedicated Ethereum (ETH) treasury organization.
That same day, the company’s shares began trading under the new ticker “ETHZ,” marking a strategic shift towards acquiring and managing one of the largest corporate ETH holdings on public markets.
“Today, we are embracing our identity as ETHZilla and our commitment to developing a market-leading strategy that seeks to deliver the value of Ethereum to investors in the public markets,” stated McAndrew Rudisill, Executive Chairman of the Board of Directors.
With an average purchase price of $3,902, the 94,675 ETH holdings are currently valued at around $419 million, indicating a rising institutional interest in Ethereum as a treasury asset.
ETHZilla’s Institutional Support and Move into Ethereum
ETHZilla’s announcement underscores a treasury strategy focused on leveraging Ethereum as both a store of value and a yield-generating asset. The company is partnering with Electric Capital to boost returns through staking, DeFi lending, and liquidity provision, positioning itself to harness the wider utility of Ethereum beyond just price increases.
This transformation from biotech to Ethereum treasury management follows ETHZilla’s successful $565 million private fundraising round, supported by over 60 institutional and crypto-focused investors.
This diverse group comprises a blend of institutional capital and Ethereum-native developers. Leading investors include Polychain Capital, Electric Capital, and Peter Thiel’s Founders Fund, while renowned DeFi pioneers like Sreeram Kannan from EigenLayer, Konstantin Lomashuk from Lido, and Robert Leshner from Compound lend credibility to the initiative. Their involvement signifies not only trust in ETHZilla’s strategy but also faith in Ethereum’s long-term viability as a crucial part of decentralized finance.
While ETHZilla’s treasury strategy gains attention, the company has not lost touch with its origins. It has confirmed that its legacy biotech assets will remain in its portfolio, with intentions to monetize intellectual property, and its gaming division continues to operate. This diversified strategy may provide a hedge against potential crypto market volatility, although the company’s future significantly hinges on Ethereum’s performance.